PubMed:32338224 / 6783-6934 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-OGER-BB

    {"project":"LitCovid-OGER-BB","denotations":[{"id":"T212","span":{"begin":0,"end":4},"obj":"G_3"},{"id":"T213","span":{"begin":0,"end":4},"obj":"PG_10"},{"id":"T214","span":{"begin":0,"end":4},"obj":"PR:000003622"},{"id":"T215","span":{"begin":54,"end":60},"obj":"PR:000036009"},{"id":"T216","span":{"begin":65,"end":69},"obj":"PR:000001251"},{"id":"T217","span":{"begin":88,"end":92},"obj":"PR:000001191"},{"id":"T218","span":{"begin":107,"end":111},"obj":"GO:0030154"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"ACE2 counterbalances the noxious effects exhibited by ANG II and AT1R via activation of AT2R which arrests cell growth, inflammation and fibrosis [39]."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T62","span":{"begin":107,"end":111},"obj":"Body_part"}],"attributes":[{"id":"A62","pred":"fma_id","subj":"T62","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ACE2 counterbalances the noxious effects exhibited by ANG II and AT1R via activation of AT2R which arrests cell growth, inflammation and fibrosis [39]."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T41","span":{"begin":120,"end":132},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"ACE2 counterbalances the noxious effects exhibited by ANG II and AT1R via activation of AT2R which arrests cell growth, inflammation and fibrosis [39]."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T99","span":{"begin":74,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T100","span":{"begin":107,"end":111},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"ACE2 counterbalances the noxious effects exhibited by ANG II and AT1R via activation of AT2R which arrests cell growth, inflammation and fibrosis [39]."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T38","span":{"begin":54,"end":57},"obj":"Chemical"},{"id":"T39","span":{"begin":58,"end":60},"obj":"Chemical"}],"attributes":[{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"ACE2 counterbalances the noxious effects exhibited by ANG II and AT1R via activation of AT2R which arrests cell growth, inflammation and fibrosis [39]."}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T16","span":{"begin":107,"end":118},"obj":"http://purl.obolibrary.org/obo/GO_0016049"},{"id":"T17","span":{"begin":112,"end":118},"obj":"http://purl.obolibrary.org/obo/GO_0040007"},{"id":"T18","span":{"begin":120,"end":132},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"ACE2 counterbalances the noxious effects exhibited by ANG II and AT1R via activation of AT2R which arrests cell growth, inflammation and fibrosis [39]."}

    PubMed_ArguminSci

    {"project":"PubMed_ArguminSci","denotations":[{"id":"T41","span":{"begin":0,"end":151},"obj":"DRI_Background"}],"text":"ACE2 counterbalances the noxious effects exhibited by ANG II and AT1R via activation of AT2R which arrests cell growth, inflammation and fibrosis [39]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T41","span":{"begin":0,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ACE2 counterbalances the noxious effects exhibited by ANG II and AT1R via activation of AT2R which arrests cell growth, inflammation and fibrosis [39]."}